🇺🇸 FDA
Patent

US 10874631

Altertoxin II as a selective inhibitor of Ewing family of tumor cells

granted A61KA61K31/336A61K45/06

Quick answer

US patent 10874631 (Altertoxin II as a selective inhibitor of Ewing family of tumor cells) held by The Board of Regents of the University of Texas System expires Mon Dec 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Dec 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/336, A61K45/06, A61K9/0019, A61K9/19